Health ❯ Healthcare ❯ Vaccines

mRNA Vaccines

COVID-19 Vaccines Flu Vaccines Moderna Flu Vaccine Moderna Influenza Vaccines Lipid Nanoparticles RSV Vaccines Covid-19 Vaccines Funding Cuts Mpox Vaccines Norovirus Vaccine SARS-CoV-2 Vaccines Inflammation Reduction Research Funding Delivery Systems Combination Vaccines Public Health Benefits Infectious Diseases Trans-Amplifying mRNA Vaccines Vaccine Research Cancer Immunotherapy HIV Vaccines Public Health Policy Vaccine Development Moderna mFlusiva Immunization Policy Covid-19 Enteromix Vaccine Vaccine Skepticism Vaccine Safety Concerns Thermostable Formulations Moderna Vaccine Vaccine Mandates Development and Research Seasonal Influenza Vaccines Pandemic Preparedness Moderna Spikevax Cancer Vaccines Therapeutic Applications mCombriax H5N1 Bird Flu Seasonal Flu Vaccine mRNA-1010 Safety and Effectiveness Flu Vaccine Therapeutic Vaccines Moderna mFLUSIVA Moderna's mFLUSIVA Personalized Medicine

MIT AI Identifies Excipient Mix That Makes mRNA Vaccines Stable at Room Temperature

If validated through manufacturing and regulation, the finding could remove cold‑chain barriers to wider vaccine distribution.

FDA Approves Moderna’s mFlusiva for Adults 50 and Older

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

MIT Lipid Nanoparticle Boosts mRNA Vaccine Potency at 1/100th Dose in Mice

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Phenol-Modified Lipids Improve mRNA Therapeutics by Cutting Inflammation

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Cornell Team Unveils Zwitterionic Polymer to Enhance mRNA Vaccine Delivery